About Contact Us Careers

Stereotactic Surgery Devices Market Size and Forecast, by Product (Gamma Knife, LINAC, Proton Beam Radiation Therapy (PBRT); CyberKnife); Application (Liver, Breast, Prostate, Lung, Colon); End-Use (Hospitals, Laboratories) - Growth Trends, Key Players, Regional Analysis 2026-2035

  • Report ID: 5331
  • Published Date: Sep 11, 2025
  • Report Format: PDF, PPT

Stereotactic Surgery Devices Market Outlook:

Stereotactic Surgery Devices Market size was valued at USD 27.89 Billion in 2025 and is set to exceed USD 41.68 Billion by 2035, expanding at over 4.1% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of stereotactic surgery devices is estimated at USD 28.92 Billion.

Stereotactic Surgery Devices Market Size
Discover Market Trends & Growth Opportunities: Request Free Sample PDF

The reason behind the growth is due to the rising cases of cancer across the globe. Stereotactic radiosurgery, such as Gamma Knife, is a three-dimensional surgical technique and a very precise form of therapeutic radiation that is often used to treat noncancerous (benign), cancerous (malignant) brain tumors, and also to treat small, early-stage lung cancer and pancreatic cancer, or cancers that have spread to the lung, liver, or adrenal gland.

For instance, Cancer is one of the world's top causes of death, accounting for more than 9 million deaths in 2020, and it is anticipated that by 2040, there will be more than 27 million new cancer cases worldwide.

The growing technological advancements are believed to fuel the market growth. Stereotactic radiation is constantly being improved, owing to technological advances that aid in boosting treatment precision.

Key Stereotactic Surgery Devices Market Insights Summary:

  • Regional Highlights:

    • The North America stereotactic surgery devices market is expected to capture 42% share by 2035, driven by rising government initiatives to increase cancer awareness and healthcare investments.
    • The Asia Pacific market will secure the second largest share by 2035, attributed to the rise in medical tourism, particularly in India.

  • Segment Insights:

    • The breast segment in the stereotactic surgery devices market is anticipated to capture a 25% share by 2035, attributed to the rising incidence of breast cancer and advancements in radiation therapy.
    • The linac segment in the stereotactic surgery devices market is anticipated to achieve a significant share by 2035, fueled by its popularity in non-surgical treatment of brain-related issues.

  • Key Growth Trends:

    • Rising Popularity of Minimally Invasive Procedures
    • Growing Popularity of Augmented Reality

  • Major Challenges:

    • High Initial Cost
    • Stringent Rules and Regulations to Obtain Approval for New Stereotactic Surgery Devices

  • Key Players: Koninklijke Philips N.V., Hitachi Medical Systems, Huiheng Group, Siemens AG, Elekta AB, Varian Medical Systems, IBA, Accuray Incorporated, GE Healthcare, Toshiba Energy Systems & Solutions Corporation.

Global Stereotactic Surgery Devices Market Forecast and Regional Outlook:

  • Market Size & Growth Projections:

    • 2025 Market Size: USD 27.89 Billion
    • 2026 Market Size: USD 28.92 Billion
    • Projected Market Size: USD 41.68 Billion by 2035
    • Growth Forecasts: 4.1% CAGR (2026-2035)

  • Key Regional Dynamics:

    • Largest Region: North America (42% Share by 2035)
    • Fastest Growing Region: Asia Pacific
    • Dominating Countries: United States, Germany, Japan, China, United Kingdom
    • Emerging Countries: China, Japan, South Korea, India, Malaysia

    • Last updated on : 11 September, 2025

Growth Drivers

  • Rising Popularity of Minimally Invasive Procedures – Stereotactic surgery is a minimally invasive method of surgical intervention that uses small scalp incisions to provide a safer alternative to traditional brain surgery. Moreover, it employs a three-dimensional coordinate system to pinpoint small objects inside the body without the necessity of a general anesthetic.
  • Growing Popularity of Augmented Reality- Augmented reality (AR) and virtual reality are new technologies and the next stage in the integration of stereotactic navigation into spinal surgery that allows surgeons to view three-dimensional virtual reconstructions of anatomical components placed over the surgical area on a tablet computer. 

Mobile augmented reality will become increasingly popular in the next 2-3 years, with estimates indicating that there will be more than 2 billion mobile AR users worldwide by 2023.

Challenges

  • High Initial Cost – The development of stereotactic surgery devices incorporates advanced components such as high-resolution imaging systems, and robotic arms which are expensive to produce and also involve high cost of ownership, and cost of surgical setup which may make it difficult for the technology to be adopted by a wider number of laboratories with limited budget. 

Besides this, the market for stereotactic surgery equipment is changing rapidly as a result of extensive research and development activity by leading competitors which usually costs more as these devices require a high level of precision and availability of trained professionals. Furthermore, the high cost of device maintenance also adds to the overall cost.

  • Stringent Rules and Regulations to Obtain Approval for New Stereotactic Surgery Devices
  • Lack of Awareness about the Benefits of Stereotactic Surgery

Stereotactic Surgery Devices Market Size and Forecast:

Report Attribute Details

Base Year

2025

Forecast Period

2026-2035

CAGR

4.1%

Base Year Market Size (2025)

USD 27.89 Billion

Forecast Year Market Size (2035)

USD 41.68 Billion

Regional Scope

  • North America (U.S. and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC, North Africa, South Africa, Rest of the Middle East and Africa)
Access Detailed Forecasts & Data-Driven Insights: Request Free Sample PDF

Stereotactic Surgery Devices Market Segmentation:

Application Segment Analysis

The breast segment is estimated to account for 25% share of the global stereotactic surgery devices market in the coming years owing to the rising cases of breast cancer. It is expected that smoking, exposure to carcinogenic substances, changes in other hormones caused by night shift jobs, family history, obesity, and a sedentary lifestyle raise the risk of breast cancer. This has led to an increase in demand for stereotactic surgery devices as stereotactic radiation therapy appears to be promising for elderly women with breast cancer. For instance, The FDA has authorized GammaPod, a novel breast-specific stereotactic body radiotherapy equipment designed to treat breast cancer since it can apply ablative doses with sharp gradients using stereotactic image guidance which means that the tumor receives a high dosage of radiation while the tissues surrounding it receive a considerably lesser dose that reduces the likelihood of side effects.

In 2020, there were more than 7 million women alive who had been diagnosed with breast cancer in the previous five years, making it the world's most common malignancy, which is expected to increase by more than 35% by 2040, to over 2 million cases per year.

Product Segment Analysis

Stereotactic surgery devices market from the gamma knife segment is set to garner a notable share shortly. Stereotactic radiosurgery, such as Gamma Knife, is a radiation therapy equipment that uses very accurate gamma ray beams to treat a lesion or tumor, and aberrant blood vessel forms in adults and children. Moreover, tumors and other diseases are destroyed with high-energy radiation by employing computer-aided design tools whereby instead of opening the skull to remove a tumor or lesion, gamma radiation beams are used.

Besides this, the LINAC (Linear Accelerator) segment may garner significant share during the forecast timeframe. The LINAC is presently the most often utilized device for conventional radiation and radiosurgery delivery that is becoming more common as a method of radiation therapy for cerebral arteriovenous malformations (AVMs). During treatment, the LINAC equipment moves and rotates around the target to provide radiation beams from various angles and is known as the most widely used method for delivering stereotactic radiosurgery and stereotactic body radiotherapy, respectively which is a non-surgical radiation therapy that is used to treat functional impairments and tiny brain tumors.

Our in-depth analysis of the global stereotactic surgery devices market includes the following segments:

          Product
  • Gamma Knife
  • LINAC
  •  Proton Beam Radiation Therapy (PBRT)
  • CyberKnife

          Application
  • Liver
  •  Breast
  • Prostate
  • Lung
  • Colon

          End-Use
  • Hospitals
  • Laboratories
 
Vishnu Nair
Vishnu Nair
Head - Global Business Development

Customize this report to your requirements — connect with our consultant for personalized insights and options.

Stereotactic Surgery Devices Market Regional Analysis:

North American Market Insights 

Stereotactic surgery devices market in North America is predicted to account for the largest share of 42% by 2035 impelled by the rising government initiative to increase cancer awareness. Recently 50 new actions and commitments to end cancer were announced by the President of the United States to decrease the cancer death rate and to prevent more than 3 million cancer deaths by 2047. For instance, The American Cancer Society (ACS) will develop a new curriculum and certification program for oncology professional navigators to support individuals with cancer which is an essential component in clinical settings to improve cancer outcomes in the United States, by ensuring that every cancer patient obtains timely, high-quality, and culturally competent care.

APAC Market Statistics Insights 

The APAC stereotactic surgery devices market is estimated to be the second largest, during the forecast timeframe led by growing medical tourism. India has evolved as a medical tourism hotspot that provides patients from all over the world with affordable, high-quality healthcare services.  Moreover, India was ranked 10th in the 2020-2021 Medical Tourism Index, and its reputation as a top destination for medical treatments is projected to rise in the future years. This can lead to an increase in the demand for stereotactic surgery devices in the region.

For instance, more than 1 million patients from over 75 countries visit India each year for medical, wellness, and IVF treatments, generating roughly USD 5 billion for the business, which is predicted to grow to around USD 12 billion by 2026.

Stereotactic Surgery Devices Market Share
Get Strategic Analysis by Region Now: Request Free Sample PDF

Stereotactic Surgery Devices Market Players:

    • Koninklijke Philips N.V.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Hitachi Medical Systems
    • Huiheng Group
    • Siemens AG
    • Elekta AB
    • Varian Medical Systems
    • IBA
    • Accuray Incorporated
    • GE Healthcare
    • Toshiba Energy Systems & Solutions Corporation

Recent Developments

  • Siemens AG announced to acquisition of Varian Medical Systems, Inc. to create a highly integrated portfolio of imaging, laboratory diagnostics, and artificial intelligence for the treatment of cancer, and establish a strong and trusted partner capable of supporting customers and patients across the entire cancer care. Furthermore, the acquisition will enable the company to address the growing need for personalized, data-driven diagnosis and precision cancer care and support oncology clinicians and patients in achieving better outcomes.
  • Varian Medical Systems, Inc. announced that it has obtained clearance from the FDA for the use of the first linear accelerators TrueBeam and Edge systems that are intended to accurately target tumors and other diseases using radiation. Furthermore, TrueBeam and Edge systems will be used to treat medically refractory essential tremors with stereotactic radiosurgery to improve the lives of many patients who might otherwise be forced to live with untreatable essential tremors.
  • Report ID: 5331
  • Published Date: Sep 11, 2025
  • Report Format: PDF, PPT
  • Get detailed insights on specific segments/region
  • Inquire about report customization for your industry
  • Learn about our special pricing for startups
  • Request a demo of the report’s key findings
  • Understand the report’s forecasting methodology
  • Inquire about post-purchase support and updates
  • Ask About Company-Level Intelligence Additions

Have specific data needs or budget constraints?

customer-service Inquiry Before Buying

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of stereotactic surgery devices is estimated at USD 28.92 Billion.

The global stereotactic surgery devices market size crossed USD 27.89 Billion in 2025 and is likely to expand at a CAGR of more than 4.1%, surpassing USD 41.68 Billion revenue by 2035.

The North America stereotactic surgery devices market is expected to capture 42% share by 2035, driven by rising government initiatives to increase cancer awareness and healthcare investments.

Key players in the market include Koninklijke Philips N.V., Hitachi Medical Systems, Huiheng Group, Siemens AG, Elekta AB, Varian Medical Systems, IBA, Accuray Incorporated, GE Healthcare, Toshiba Energy Systems & Solutions Corporation.

Stereotactic Surgery Devices Market Report Scope

GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

Connect with our Expert

Radhika Pawar
Radhika Pawar
Senior Research Analyst
Inquiry Before Buying Request Free Sample PDF

Copyright @ 2025 Research Nester. All Rights Reserved.

footer-bottom-logos